Brenda Robinson v. Boston Scientific Corporation , 647 F. App'x 184 ( 2016 )


Menu:
  •                             UNPUBLISHED
    UNITED STATES COURT OF APPEALS
    FOR THE FOURTH CIRCUIT
    No. 15-1441
    BRENDA L. ROBINSON; REX ROBINSON,
    Plaintiffs – Appellants,
    v.
    BOSTON SCIENTIFIC CORPORATION,
    Defendant – Appellee.
    Appeal from the United States District Court for the Southern
    District of West Virginia, at Charleston.  Joseph R. Goodwin,
    District Judge. (2:12-cv-03700)
    Argued:   March 22, 2016                   Decided:   April 26, 2016
    Before SHEDD, THACKER, and HARRIS, Circuit Judges.
    Affirmed by unpublished per curiam opinion.
    ARGUED: Jessica Ann Kasischke, FLEMING, NOLEN & JEZ, L.L.P.,
    Houston, Texas, for Appellants.  Daniel Brandon Rogers, SHOOK,
    HARDY & BACON L.L.P., Miami, Florida, for Appellee.    ON BRIEF:
    Karen  Beyea-Schroeder, Sylvia   Davidow,  Kelsey   L.   Stokes,
    FLEMING, NOLEN & JEZ, L.L.P., Houston, Texas, for Appellants.
    Michael Bonasso, Charleston, West Virginia, Lindsey M. Saad,
    FLAHERTY SENSABAUGH & BONASSO PLLC, Morgantown, West Virginia,
    for Appellee.
    Unpublished opinions are not binding precedent in this circuit.
    PER CURIAM:
    Brenda    and   Rex    Robinson 1       appeal   the    grant     of   summary
    judgment in favor of Boston Scientific Corporation. The district
    court concluded that the Robinsons’ claims are barred by Utah’s
    two-year statute of limitations for product liability actions.
    We affirm, albeit on slightly different reasoning.
    I.
    Brenda Robinson, a Utah resident, sought treatment from Dr.
    Clayton Wilde, an OB/GYN, for urinary stress incontinence and
    urinary tract infections. In June 2006, Dr. Wilde recommended
    implantation of a transvaginal surgical mesh to alleviate her
    symptoms. A transvaginal surgical mesh implant treats medical
    conditions       of   the   female   pelvis,      most   commonly       pelvic   organ
    prolapse and stress urinary incontinence. The mesh is implanted
    into the anterior vaginal wall to help restore a woman’s regular
    anatomy.    Robinson        consented   to      the   procedure,    and    Dr.   Wilde
    implanted her with Boston Scientific’s Obtryx sling in Salt Lake
    City.
    During      a    post-surgical     examination,      Dr.    Wilde     instructed
    Robinson that she should “avoid intercourse for another month
    and try to make sure that she doesn’t get any pressure on her
    1
    Because Rex Robinson’s claims are derivative of his
    wife’s, we refer only to Brenda Robinson unless otherwise noted.
    2
    anterior vaginal wall and promote an erosion.” (J.A. 611). At
    another post-surgical visit, Dr. Wilde noted that he discussed
    possible   mesh   erosion   “most   likely   related   to   intercourse.”
    (J.A. 611).
    Several months later, in January 2007, Robinson returned
    due to continued urinary problems as well as pain during sexual
    intercourse (dyspareunia). During a visit on April 25, 2007, Dr.
    Wilde noted some erosion of the tape and Robinson recalled Dr.
    Wilde telling her that the mesh was “hanging down a little.”
    (J.A. 318). Dr. Wilde recommended trimming the mesh and, in May
    2007, conducted a revision surgery to remove the eroded portion
    of the mesh. In his deposition, Dr. Wilde expressed his belief
    that in cases where the mesh did not work as hoped, the erosion
    was:
    [D]irectly related to two things: Number one is the
    person’s  estrogen  status.   People  who   have  low
    estrogen, who have thin vaginal mucosa, their mucosa
    does not heal well and doesn’t have good blood supply
    to it.
    And the second one is intercourse, which is as a
    problematic event because you’re better off having
    these people not have intercourse for three months,
    but that’s unacceptable to their partner.
    And one of the things—and I did that with her, was
    told her that she shouldn’t have intercourse for a
    more extended period of time. It does not allow the
    mucosa to grow over and get good and thick. It just
    keeps getting roughed off.
    (J.A. 595).
    3
    Following the revision surgery, Robinson continued to seek
    treatment for symptoms, including bleeding, dyspareunia, urinary
    tract infections, and incontinence. Robinson’s husband likewise
    explained that “it got worse again as time went on,” (J.A. 193),
    and that the mesh “felt sharper and sharper,” (J.A. 195).
    In    February    2012,       almost    five   years       after    her       revision
    surgery,      Robinson        saw     a      television         advertisement         about
    complications     from    transvaginal           surgical       mesh.     In    response,
    Robinson sought a second opinion about her mesh and eventually
    had   the   entire     mesh    extracted.        Shortly    after       the    extraction
    surgery, Robinson commenced this action for actual and punitive
    damages against Boston Scientific in the United States District
    Court for the District of Utah for negligence, strict liability
    design defect, manufacturing defect, failure to warn, breach of
    express and implied warranties under the Utah Product Liability
    Act (UPLA). Her husband brought a derivative action for loss of
    consortium.     The    case     was       transferred      to    the     Multi-District
    Litigation (MDL) in the Southern District of West Virginia for
    pretrial proceedings.
    Following      discovery,       Boston     Scientific       moved       for   summary
    judgment, arguing that all of Robinson’s claims are barred by
    Utah’s two-year statute of limitations for defective products.
    The district court granted that motion, concluding that the two-
    year limitations period began to run on April 25, 2007, when Dr.
    4
    Wilde told Robinson that the mesh was hanging down and causing
    the dyspareunia. In re Boston Scientific Corp., 
    2015 WL 1466746
    (S.D. W.Va. 2015). The district court also found Mr. Robinson’s
    derivative claims are barred. The Robinsons timely appealed.
    II.
    We review the grant of summary judgment de novo. Wilkins v.
    Montgomery, 
    751 F.3d 214
    , 220 (4th Cir. 2014). The parties agree
    that Utah substantive law governs this diversity action. The
    UPLA provides:
    A civil action under this part shall be brought within
    two years from the time the individual who would be
    the claimant in the action discovered, or in the
    exercise of due diligence should have discovered, both
    the harm and its cause.
    U.C.A. § 78B-6-706 (2008).
    Under       Utah    law,    “all        that        is    required    to    trigger     the
    statute       of        limitations       is     sufficient             information       to   put
    plaintiffs         on    notice    to    make     further          inquiry    if   they    harbor
    doubts or questions.” Macris v. Sculptured Software, Inc., 
    24 P.3d 984
    ,       990     (Utah        2001).        In        cases   involving     defective
    products, the limitations period begins to run when a plaintiff
    knows or should know: (1) that she has been injured; (2) the
    identity of the maker of the allegedly defective product; and
    (3)    that    the       product   had     a     possible          causal    relation     to   her
    injury. Aragon v. Clover Club Foods Co., 
    857 P.2d 250
    , 252-53
    (Utah Ct. App. 1993).
    5
    Robinson argues that the district court misconstrued Utah
    law by failing to require Boston Scientific to show that she
    knew the mesh was the cause-in-fact of her injury. Robinson also
    argues that, even under the “possible causal relation” standard
    employed by the district court, she has raised a genuine issue
    of material fact as to whether she should have known, on April
    25, 2007, that the mesh was a possible cause of her harm. 2
    For    purposes      of    this    appeal,    we    will     accept    Robinson’s
    argument that, under Utah law, “possible causal relationship”
    refers to the cause-in-fact. Even accepting Robinson’s view of
    Utah law, however, we conclude that her claims are untimely. As
    the nonmoving party at summary judgment, Robinson is entitled to
    all reasonable inferences in her favor. T-Mobile Northeast, LLC
    v. City Council of Newport News, 
    674 F.3d 380
    , 384-85 (4th Cir.
    2012).    In    this    case,   that    includes    the        reasonable    inference
    that,    during    the    April     25,    2007,    office        visit,    Dr.    Wilde
    informed Robinson that the mesh was hanging down but linked the
    erosion    to     Robinson’s      own    actions—her          resumption    of    sexual
    intercourse      with    her    husband    before       the    healing     process   was
    complete—rather than a product defect. Dr. Wilde’s comments to
    2 Robinson makes two additional arguments: that the district
    court improperly applied the summary judgment standard and that
    she raised a genuine issue of material fact as to the identity
    of the manufacturer. We have reviewed these claims and find them
    to be without merit.
    6
    Robinson          on    that    date     thus   might    not    have   led   Robinson     to
    believe that the mesh was the cause-in-fact of her harm.
    However, Dr. Wilde also told Robinson that the revision
    surgery would alleviate these symptoms. Despite this assurance,
    after       Dr.    Wilde       performed    the      revision    surgery     in   May   2007
    Robinson continued to have the same symptoms. Specifically, both
    Robinson and her husband continued to have dyspareunia and her
    husband could still feel the mesh. At this point, Robinson was
    on inquiry notice of a possible causal relationship between the
    mesh and her harm. In other words, when the revision surgery
    failed       to        correct     her    symptoms,      Robinson      had    “sufficient
    information”            to   put   her    “on   notice    to    make   further    inquiry”
    about the cause-in-fact of her harm. Macris, 24 P.3d at 990. 3
    At the very least, Robinson had sufficient information by
    the end of 2007 when the revision surgery failed to correct her
    3
    Robinson’s argument to the contrary—that her limitations
    period did not begin until she became subjectively aware that
    the mesh was causing her harm in 2012—contradicts Utah’s purpose
    in imposing a statute of limitations: “to compel the exercise of
    a right of action within a reasonable time and to suppress stale
    and fraudulent claims so that claims are advanced while evidence
    to rebut them is still fresh.” Craftsman Builder’s Supply, Inc.
    v. Butler Mfg. Co., 
    974 P.2d 1194
    , 1198 (Utah 1999) (internal
    quotation marks omitted). In Robinson’s view, the advertisement
    was happenstance. Had she not seen it (or something like it),
    her limitations period would have remained tolled until the date
    she did, regardless of when (if ever) that might occur. That
    potential for open-endedness runs afoul of Utah’s desire to
    compel actions in a “reasonable time.”
    7
    symptoms. By that point, Robinson was on inquiry notice that the
    mesh could be the cause-in-fact of her harm and was required to
    perform due diligence to determine if it was the actual cause. 4
    Accordingly, her claims, and her husband’s derivative claims,
    are barred by Utah’s two-year statute of limitations.
    III.
    For the foregoing reasons, the judgment of the district
    court is affirmed.
    AFFIRMED
    4 Because the cause-in-fact standard is more stringent than
    the possible cause standard the district court applied, it
    follows that, if Robinson was on inquiry notice that the sling
    was a cause-in-fact by the end of 2007, she was also on notice
    that it was a possible cause.
    8
    

Document Info

Docket Number: 15-1441

Citation Numbers: 647 F. App'x 184

Filed Date: 4/26/2016

Precedential Status: Non-Precedential

Modified Date: 1/13/2023